Location: Home
  • search
  • go
  • Relate News
  • 11/6/2025Innorna Reportedly Targets $200M Hong Kong IPO to Accelerate Drug Deve...
  • 11/5/2025CSL Behring Expands Partnership with Baiyang Pharma for Albumin Produc...
  • 11/5/2025Merck Secures $700M Funding from Blackstone for TROP2-Targeting ADC C...
  • 11/5/2025TransThera Signs up to US$881.5M Global Deal with Neurocrine for NLRP...
  • 11/5/2025US Dollar Funds Make a Comeback in China's Innovative Drug Market: VBD...
  • 11/5/2025CDE Grants Breakthrough Therapy Designation to Ivonescimab for Triple-...
  • 11/5/2025China to Expand Use of Artificial Intelligence Across Health Sector by...
  • 11/5/2025Bayer Deepens Investment in China's Booming Biopharma Sector
  • 11/5/2025Senior CSPC Executive Fined CNY 5M for Insider Trading
  • 11/5/2025China Expands Drug Access Through 11th National Bulk-Buy and New 2025 ...
  • 11/5/2025Lumosa's Stroke Drug Achieves Phase IIb Success in China
  • 11/5/2025AbbVie's CD20×CD3 Bispecific Epcoritamab Fails to Win China Approval
  • 11/5/2025Bloomberg: China Has Another Trade Weapon Waiting for America — Pharm...
  • 11/5/2025MNCs Retreat as China Cancels Dozens of Branded Medicines Amid Price C...
  • 11/5/2025China Wraps Up 2025 Drug Negotiation: Dual Catalogs Debut, Innovative ...
  • 11/4/2025Genscript Secures NMPA IND Clearance for Second Bispecific ADC GenSci1...
  • 11/4/2025Abbisko Begins Phase II Trial of Oral PD-L1 Inhibitor ABSK043 in Combo...
  • 11/4/2025Everest Acquires Exclusive Greater China and Other Asian Country Right...
  • 11/4/2025CStone Receives NMPA IND Approval for Phase II Trials of CS2009
  • 11/4/2025China to Include HPV Vaccines in National Immunization Program
  • 11/4/2025Lupeng Pharma's Hong Kong IPO Application Accepted
  • 11/4/2025Alebund Pharma's Hong Kong IPO Application Accepted
  • 11/4/2025NovaBridge Biosciences (I-Mab) Files for Hong Kong IPO
  • 11/4/2025Huadong Medicine Initiates Phase I Trial of CDH17-Targeting ADC HDM201...
  • 11/4/2025Lepu Licenses GLP-1/GIP/FGF21 Agonist MWN105 to Sidera in US$1.05B Dea...
  • 11/4/2025CDE Seeks Comments on the 100th Batch of Reference Formulations for Ch...
  • 11/4/2025CDE Invites Comments on the Draft Technical Guidelines for Dose Extrap...
  • 11/4/2025NHSA Introduces New Measure to Strengthen Intelligent Oversight of Exc...
  • 11/4/2025China's BMI Fund Maintains Strong Surplus in First Three Quarters of 2...
  • 10/31/2025NMPA Grants Conditional Approval for Lepu Biotech's Becotatug Vedotin
  • Page:6/803 Total number of articles:24077: [First][<<] [4] [5] [6] [7] [8] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group